Celgene stirs up maelstrom with PR for thalidomide

Article Abstract:

Celgene Corp of Warren, NJ, faces huge PR obstacles in marketing its thalidomide-based leprosy drug called Thalomid. Thalidomide is the infamous drug that caused thousands of birth defects during the 1950s and 1960s. Handling the PR job is Makovsky & Co, which has worked closely with the government, medical community and thalidomide victims to create a program designed to prevent another tragedy.

Pharmaceutical Preparation Manufacturing, Public affairs, Antibacterial & Antiseptic Preps

---

Food groups use 'Net to combat biotech hysteria

Article Abstract:

The Alliance for Better Foods, composed of food producers and marketers, is pushing for a 'fact-based' discussion on the importance of biotech foods. The coalition also offers a Web site, www.betterfoods.org, developed by BSMG's Washington DC office. The site highlights the improved yields from biotech crops as well as a future wherein a child can get a vaccine by eating a biotech banana.

Food Manufacturing, Food & Kindred Products

---

Similar abstracts:

• Abstracts: Building brand loyalty: marketers use both travel and merchandise to hold customers. Speeding the reward process: desire for instant gratification drives new promotions
• Abstracts: Crossing the border. Teen talk for teens only. Centenary book captures newspaper's local history
• Abstracts: Kid power. Chicken of the Sea builds brand awareness with CD-ROM offer
• Abstracts: Thailand's domestic debt and equity markets return to life. Public sector: Bangchak Petroleum
• Abstracts: Valuing fixed-income options and mortgage-backed securities with alternative term structure models. Discussion of 'Post-IPO directors' Sales and Reissuing Activity: An Empirical Test of IPO Signalling Models.'

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.